Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza

BACKGROUND: Vaccination against seasonal influenza strains is recommended for “high risk” patient groups such as infants, elderly and those with respiratory or circulatory diseases. However, efficacy of the trivalent influenza vaccine (TIV) is poor in many cases and in the event of an influenza pand...

Descripción completa

Detalles Bibliográficos
Autores principales: Heath, M. D, Swan, N. J., Marriott, A. C., Silman, N. J., Hallis, B., Prevosto, C., Gooch, K. E., Skinner, M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369220/
https://www.ncbi.nlm.nih.gov/pubmed/28347293
http://dx.doi.org/10.1186/s12879-017-2329-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369220/
https://www.ncbi.nlm.nih.gov/pubmed/28347293
http://dx.doi.org/10.1186/s12879-017-2329-5

Ejemplares similares